Kite Pharma, Inc.

Kite Pharma, Inc.

Kite Pharma, Inc.

Overview
Date Founded

2009

Headquarters

2225 Colorado Avenue, Santa Monica, CA, 90404, USA

Type of Company

Private

Employees (Worldwide)

185

Industries

Biotechnology
Hospitals & Patient Services
Medical Support Services

Company Description

Kite Pharma, Inc. engages in the the development and commercialization of cancer immunotherapy products. Its products include chimeric antigen receptor (CAR) and T cell receptor (TCR), which address both hematological and solid cancers. The company was founded by Arie S. Belldegrun, James S. Economou, and Joshua A. Kazam in June 2009 and is headquartered in Santa Monica, CA.

Contact Data
Trying to get in touch with decision makers at Kite Pharma, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Founder

Chief Executive Officer

Senior Vice President & Global Head-Technical Operations

Senior Vice President, Clinical Development

Senior Vice President-Regulatory Affairs

Vice President, Quality & Operations

Vice President, Translational Medicine

Founder

Chief Financial Officer

Senior Vice President & Global Head of Cell Therapy Research

Board of Directors

Chief Legal & Business Officer, Corporate Secretary at Assembly Biosciences, Inc.

Paths to Kite Pharma, Inc.
Potential Connections via
Relationship Science
You
Kite Pharma, Inc.
Recent Transactions
Details Hidden

Gilead Sciences, Inc. purchases Kite Pharma, Inc.

Details Hidden

Kite Pharma, Inc. issued USD Common Stock

Details Hidden

Kite Pharma, Inc. issued USD Common Stock

Transaction Advisors
Investment Advisor

Advised onGilead Sciences, Inc. purchases Kite Pharma, Inc.

Investment Advisor

Advised onGilead Sciences, Inc. purchases Kite Pharma, Inc.

Escrow Agent

Advised onKite Pharma, Inc. issued USD Common Stock

Legal Advisor

Advised onKite Pharma, Inc. issued USD Common Stock

Legal Advisor

Advised onKite Pharma, Inc. issued USD Common Stock

Associate

Advised onKite Pharma, Inc. issued USD Common Stock

Advisors & Consultants
Legal Advisor

Partner, San Diego at Cooley LLP

Legal Advisor

Co-Chair, Mergers & Acquisitions at Cooley LLP

Advisor

Former Chief Medical Officer at Kite Pharma, Inc.

Clients

Amgen, Inc. is a biotechnology medicines company, which discovers, develops, manufactures and markets medicines for grievous illnesses. The company focuses on human therapeutics and concentrates on innovating novel medicines based on advances in cellular and molecular biology. It markets recombinant protein therapeutics in supportive cancer care, nephrology and inflammation. The company's products include Neulasta, a pegylated protein, based on the Filgrastim molecule and NEUPOGEN, a recombinant-methionyl human granulocyte colony stimulating factor both of which selectively stimulate the production of neutrophils; Enbrel, an inhibitor of tumor necrosis factor, a substance that plays a role in the body's response to inflammatory diseases; Sensipar/Mimpara, a small molecule calcimimetic that lowers serum calcium levels; Vectibix, a monoclonal antibody that binds specifically to the epidermal growth factor receptor; and Nplate, a thrombopoietin receptor agonist that mimics endogenous TPO, the primary driver of platelet production. Amgen was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

Daiichi Sankyo Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceuticals. Its products include drugs for the field of oncology such as Trastuzumab deruxtecan, Anti-HER3-ADC, Quizartinib, Milademetan, Valemetostat, Pexidartinib, Edoxaban, Prasugel, and Microgabalin. The company was founded on September 28, 2005 and is headquartered in Tokyo, Japan.

Key Stats and Financials As of
Market Capitalization
$10.3B
Total Enterprise Value
Earnings Per Share
Non-Profit Donations & Grants
Investments
Details Hidden

Cell Design Labs, Inc. develops disruptive cell-based therapies for cancer and other devastating diseases. The company was founded by Brian G. Atwood and Fred E. Cohen in 2016 and is headquartered in Emeryville, CA.

Details Hidden

HiFiBiO Inc. develops and manufactures pharmaceutical products. It specializes in antibodies, that mobilize the human immune system to combat cancer, autoimmune disorders, and other unmet medical needs. The company was founded by Liang Schweizer, Fred Dom, Andrew Griffiths, David Weitz, Bradley Bernstein, Jérôme Bibette, and Robert Nicol and is headquartered in Paris, France.

Details Hidden

Gadeta BV discovers and develops novel cancer immunotherapies. It provides groundbreaking discoveries regarding the role of cell receptors in the broad of heamatological and solid tumor cells. The firm develops t-cells engineered to express a defined gamma delta, an anti- cancer product that eradicates tumors. The company was founded by Jurgen Kuball in 2015 and is headquartered in Utrecht, Netherlands.

Investors
Details Hidden

Two River Group Holdings invests in companies located in US. The firm focuses on companies operating in the fields of life sciences and healthcare sectors. They provide financing for early stage capital requirements.

Details Hidden

Alta Partners Management Corp. specializes in investments in healthcare venture capital companies. The firm looks for Technology enabled solutions and services that improve delivery and quality of care with Strong entrepreneurs

Details Hidden

Former Chief Medical Officer at Kite Pharma, Inc.

Suppliers
Government of the United States of America Holding Companies | Washington, DC

The Government of the United States of America is the federal government of the republic of fifty states that constitute the United States, as well as one capital district, and several other territories. The federal government is composed of three distinct branches: legislative, executive and judicial, whose powers are vested by the U.S. Constitution in the Congress, the President, and the federal courts, including the Supreme Court, respectively.

IBA GmbH Hospitals & Patient Services | Goettingen, Germany

IBA GmbH provides product and service solutions for life science research. Its product and service portfolio includes cell selection and expansion, cloning, transfection, recombinant protein production and assays to nucleic acid custom services. The company was founded in 1999 and is headquartered in Göttingen, Germany.

Sanquin Blood Supply Foundation Hospitals & Patient Services | Amsterdam, Netherlands

Sanquin Blood Supply Foundation provides blood supplies. Its products and services include diagnostic services , consulting services, reagents, DNA paternity testing, biological, laboratory for cell therapy, immunomonitoring services and plasma products. The company is headquartered in Amsterdam, the Netherlands.

Competitors
Novartis AG Pharmaceuticals - Basel, Switzerland

Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals. The Sandoz segment develops, manufactures and markets finished dosage form medicines as well as intermediary products including active pharmaceutical ingredients. The Corporate segment refers to group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.

Bristol-Myers Squibb Company Pharmaceuticals - New York, New York

Bristol-Myers Squibb Company Our company has a strong legacy of innovation that began in New York in 1858 when Edward R. Squibb, M.D., founded a pharmaceutical company in Brooklyn, and in 1887 when two friends, William McLaren Bristol and John Ripley Myers purchased a struggling drug manufacturing firm in Clinton. Together, they laid the foundation for our company today — a global BioPharma leader that continues this legacy of innovation.

bluebird bio, Inc. Biotechnology - Cambridge, MA

bluebird bio, Inc. is a clinical-stage biotechnology company, which engages in the development of potential gene therapies for severe genetic diseases and cancer. Its integrated product platform includes gene therapy, cancer immunotherapy, and gene editing. Its product pipeline includes Lenti-D, LentiGlobin, BCL11a shRNA, bb2121, and bb21217. The company was founded by Philippe Leboulch and Ronald C. Dorazio on April 16, 1992 and is headquartered in Cambridge, MA.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Kite Pharma, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Kite Pharma, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Kite Pharma, Inc..